125 related articles for article (PubMed ID: 9743227)
1. Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN.
Rand ML; Sangrar W; Hancock MA; Taylor DM; Marcovina SM; Packham MA; Koschinsky ML
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1393-9. PubMed ID: 9743227
[TBL] [Abstract][Full Text] [Related]
2. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.
Kinlough-Rathbone RL; Perry DW; Packham MA
Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483
[TBL] [Abstract][Full Text] [Related]
5. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
6. Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation.
Suzuki H; Packham MA; Kinlough-Rathbone RL
Exp Mol Pathol; 1995 Feb; 62(1):63-72. PubMed ID: 7556592
[TBL] [Abstract][Full Text] [Related]
7. The Ca2+-mobilizing potency of alpha-thrombin and thrombin-receptor-activating peptide on human platelets -- concentration and time effects of thrombin-induced Ca2+ signaling.
Heemskerk JW; Feijge MA; Henneman L; Rosing J; Hemker HC
Eur J Biochem; 1997 Oct; 249(2):547-55. PubMed ID: 9370366
[TBL] [Abstract][Full Text] [Related]
8. [Role of adenosine diphosphate in the course of thrombin signal transmission].
Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
[TBL] [Abstract][Full Text] [Related]
9. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
10. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin.
Kinlough-Rathbone RL; Perry DW; Guccione MA; Rand ML; Packham MA
Thromb Haemost; 1993 Dec; 70(6):1019-23. PubMed ID: 8165594
[TBL] [Abstract][Full Text] [Related]
11. Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function.
Rand ML; Jakubowski JA; Fisher MJ; Chahil A; Kinlough-Rathbone RL; Packham MA
J Lab Clin Med; 2002 Dec; 140(6):391-7. PubMed ID: 12486406
[TBL] [Abstract][Full Text] [Related]
12. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
13. Apoprotein (A) antagonises THE GPIIB/IIIA receptor on collagen and adp-stimulated human platelets.
Barre DE
Front Biosci; 2004 Jan; 9():404-10. PubMed ID: 14766377
[TBL] [Abstract][Full Text] [Related]
14. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
[TBL] [Abstract][Full Text] [Related]
15. Differences between platelet phosphoinositide metabolism stimulated by thrombin or SFLLRN are not accounted for by interaction of thrombin with glycoprotein Ib.
Vickers JD; Packham MA; Kinlough-Rathbone RL
Am J Hematol; 1997 Apr; 54(4):288-95. PubMed ID: 9092683
[TBL] [Abstract][Full Text] [Related]
16. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
17. Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation.
Chow TW; Hellums JD; Thiagarajan P
J Lab Clin Med; 2000 Jan; 135(1):66-72. PubMed ID: 10638696
[TBL] [Abstract][Full Text] [Related]
18. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
Gross PL; Rand ML; Barrow DV; Packham MA
Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
[TBL] [Abstract][Full Text] [Related]
19. Species differences in platelet responses to thrombin and SFLLRN. receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases.
Derian CK; Santulli RJ; Tomko KA; Haertlein BJ; Andrade-Gordon P
Thromb Res; 1995 Jun; 78(6):505-19. PubMed ID: 15714752
[TBL] [Abstract][Full Text] [Related]
20. Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction.
Lasne D; Donato J; Falet H; Rendu F
Thromb Haemost; 1995 Nov; 74(5):1323-8. PubMed ID: 8607117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
